Pharm Tech Europe Alert E-Newsletter

10 May 2016

To view this newsletter online, paste this url in your browser:

<http://images2.advanstar.com/pharmtech/eNews/2016/PTE_05102016/PTE_05102016.html>

--------------------------------------------------------------------

Pharm Tech Europe 05102016



--------------------------------------------------------------------

Billing Code: 06-003361-45-4300-EN0361


--------------------------------------------------------------------

Mail Date: 


From line: Rita Peters, Editorial Director, Pharmaceutical Technology

Subject Line: Regulators Lift Suspension on Catalent Softgel Facility; IMS Health Holdings and Quintiles to Combine


-------------------------------------------------------------------------------------------------------------

Mail Date: 


mohamed.moulana@mpe.hcl.com


Forward: <a href="ECN_Social_F2F">

ECN_Social_F2F


<a href="mailto:?Subject=BMS Makes Changes in R&D Focus; Celgene Pays $1 Billion for Partnership with Juno Therapeutics &amp;Body=A colleague would like to share the Pharmaceutical Technology Europe eNews with you. Please view the email at the following link: http://images2.advanstar.com/pharmtech/eNews/2015/PTE_07072015_responsive/PTE_07072015_Responsive.html" target="_blank" style="background: #233f6d; color: #fff; font-family: 'Century Gothic', CenturyGothic, AppleGothic, sans-serif; font-size: 12px; font-weight: bold; padding: 3px 5px; text-decoration: none">
                                    <span>  </span>FORWARD<span>  </span>
                                  </a>

&euro;